GLP-1 Related Skin Changes

What Is Happening to the Skin

GLP-1 receptor agonists, including semaglutide and tirzepatide, have become widely used for metabolic health and weight management. The weight loss they produce can be significant and relatively rapid. When fat is lost quickly, the face loses volume before the skin has time to adapt, resulting in a gaunt or deflated appearance that patients and practitioners commonly refer to as "Ozempic face."

The changes associated with rapid weight loss are structural. The fat compartments that support the midface, fill the temples, and define the jawline are reduced, and the overlying skin, which was previously supported by that volume, begins to sag, crease, and lose its tautness. The result is an appearance of accelerated aging that is disproportionate to the patient's age.

Common Presentations

The most frequently reported concerns include:

• Hollowing beneath the eyes and in the temples
• Deepening nasolabial folds and marionette lines
• Jowling and loss of jawline definition
• Crepey or lax skin on the neck and lower face
• An overall appearance of premature aging disproportionate to the patient's chronological age

What Can Be Done

The aesthetic changes associated with GLP-1 medications are addressable. The approach depends on the degree of volume loss and the distribution of laxity. Dermal fillers can restore volume to the midface, tear troughs, and jawline. Biostimulators, including Sculptra and Radiesse, encourage long-term collagen production for patients who require more structural rebuilding. For patients with significant skin laxity, energy-based treatments such as Thermage or Morpheus8 may be incorporated into the plan.

Treatment is most effective when approached gradually and in proportion. Your practitioner will assess your anatomy, the rate and degree of change, and your goals before recommending a sequenced plan.

Timing Considerations

If you are still actively losing weight, your practitioner may advise waiting until your weight has stabilized before beginning restorative treatment. Volume restoration done during active loss may need to be revised as your facial structure continues to change.